Study on the chemotherapeutic effect and mechanism of cucurbitacin E on laryngeal cancer stem cells
暂无分享,去创建一个
[1] S. Maurya,et al. Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance. , 2020, Seminars in cancer biology.
[2] P. Stiuso,et al. A possible interplay between HR‐HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18‐infected KB cell line , 2020, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[3] Zihan Xu,et al. [The Effect of Morusin on Stemness Phenotype of Laryngeal Cancer Stem Cell]. , 2020, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.
[4] Yanzhong Xin,et al. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway , 2020, Anti-cancer drugs.
[5] C. Gopu,et al. Enhancement of production of pharmaceutically important anti-cancerous compound; cucurbitacin E via elicitation and precursor feeding of in vitro culture of Citrullus colocynthis (L.) Schard , 2020, Vegetos.
[6] T. Efferth,et al. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[7] Weiyi Wang,et al. Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[8] M. Szczepański,et al. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1). , 2019, European journal of pharmacology.
[9] T. Efferth,et al. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[10] H. Wu,et al. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs]. , 2019, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.
[11] Yi-Chiang Hsu,et al. The effects of cucurbitacin E on GADD45β‐trigger G2/M arrest and JNK‐independent pathway in brain cancer cells , 2019, Journal of cellular and molecular medicine.
[12] Zhe-Sheng Chen,et al. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. , 2018, Cancer letters.
[13] Wei Wang,et al. MPEG-CS/Bmi-1RNAi Nanoparticles Synthesis and Its Targeted Inhibition Effect on CD133+ Laryngeal Stem Cells. , 2018, Journal of nanoscience and nanotechnology.
[14] G. Qing,et al. Targeting oncogenic Myc as a strategy for cancer treatment , 2018, Signal Transduction and Targeted Therapy.
[15] F. Rahmani,et al. Comparison between the effects of potassium phosphite and chitosan on changes in the concentration of Cucurbitacin E and on antibacterial property of Cucumis sativus , 2017, BMC Complementary and Alternative Medicine.
[16] Yi-Chiang Hsu,et al. Inducement of apoptosis by cucurbitacin E, a tetracyclic triterpenes, through death receptor 5 in human cervical cancer cell lines , 2017, Cell Death Discovery.
[17] Yongyan Wu,et al. Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines , 2017, Journal of Cancer.
[18] Ying Wang,et al. Cucurbitacin E inhibits osteosarcoma cells proliferation and invasion through attenuation of PI3K/AKT/mTOR signalling pathway , 2016, Bioscience reports.
[19] Liang Zhou,et al. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma]. , 2007, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.
[20] Liang Zhou,et al. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma]. , 2006, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.